Paolo Girardi

Prof. Paolo Girardi

Department of Clinical and Dynamic Psychology, Faculty of Medicine and Psychology, Sapienza University, Rome, Italy

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Maurizio PompiliMaurizio Pompili
Maurizio Pompili
Gianluca SerafiniGianluca Serafini
Gianluca Serafini
Marco InnamoratiMarco Innamorati
Marco Innamorati
GDGiovanni Dominici
Giovanni Dominici
Stefano FerracutiStefano Ferracuti
Stefano Ferracuti
David LesterDavid Lester
David Lester
Suicide is an escalating public health problem, and alcohol use has consistently been implicated in the precipitation of suicidal behavior. Alcohol abuse may lead to suicidality through disinhibition, impulsiveness and impaired judgment, but it may also be used as a means to ease the distress associated with committing an act of suicide. We reviewed evidence of the relationship between alcohol use and suicide through a search of MedLine and PsychInfo electronic databases. Multiple genetically-related intermediate phenotypes might influence the relationship between alcohol and suicide. Psychiatric disorders, including psychosis, mood disorders and anxiety disorders, as well as susceptibility to stress, might increase the risk of suicidal behavior, but may also have reciprocal influences with alcohol drinking patterns. Increased suicide risk may be heralded by social withdrawal, breakdown of social bonds, and social marginalization, which are common outcomes of untreated alcohol abuse and dependence. People with alcohol dependence or depression should be screened for other psychiatric symptoms and for suicidality. Programs for suicide prevention must take into account drinking habits and should reinforce healthy behavioral patterns.

16 March 2007 in Annals of General Psychiatry
Verified
Journal Article
Open access
PDF file
Maurizio PompiliMaurizio Pompili
Maurizio Pompili
XAXavier F Amador
Xavier F Amador
Paolo GirardiPaolo Girardi
Paolo Girardi
JHJill Harkavy-Friedman
Jill Harkavy-Friedman
MHMartin Harrow
Martin Harrow
RTRoberto Tatarelli
Roberto Tatarelli
Suicide is a major cause of death among patients with schizophrenia. Research indicates that at least 5–13% of schizophrenic patients die by suicide, and it is likely that the higher end of range is the most accurate estimate. There is almost total agreement that the schizophrenic patient who is more likely to commit suicide is young, male, white and never married, with good premorbid function, post-psychotic depression and a history of substance abuse and suicide attempts. Hopelessness, social isolation, hospitalization, deteriorating health after a high level of premorbid functioning, recent loss or rejection, limited external support, and family stress or instability are risk factors for suicide in patients with schizophrenia. Suicidal schizophrenics usually fear further mental deterioration, and they experience either excessive treatment dependence or loss of faith in treatment. Awareness of illness has been reported as a major issue among suicidal schizophrenic patients, yet some researchers argue that insight into the illness does not increase suicide risk. Protective factors play also an important role in assessing suicide risk and should also be carefully evaluated. The neurobiological perspective offers a new approach for understanding self-destructive behavior among patients with schizophrenia and may improve the accuracy of screening schizophrenics for suicide. Although, there is general consensus on the risk factors, accurate knowledge as well as early recognition of patients at risk is still lacking in everyday clinical practice. Better knowledge may help clinicians and caretakers to implement preventive measures. This review paper is the results of a joint effort between researchers in the field of suicide in schizophrenia. Each expert provided a brief essay on one specific aspect of the problem. This is the first attempt to present a consensus report as well as the development of a set of guidelines for reducing suicide risk among schizophenia patients.

AFAlberto Forte
Alberto Forte
FTFederico Trobia
Federico Trobia
FGFlavia Gualtieri
Flavia Gualtieri
DLDorian Lamis
Dorian Lamis
GCGiuseppe Cardamone
Giuseppe Cardamone
Maurizio PompiliMaurizio Pompili
Maurizio Pompili
Recent studies have demonstrated that immigrants and ethnic minorities may be at higher risk of suicidal behaviour as compared to the general population. We conducted a literature search to identify studies in English from 1980 to 2017 related to suicide risk among immigrants and ethnic minorities. Six hundred and seventy-eight reports were screened, and 43 articles were included in the qualitative synthesis of the review. Some studies reported lower rates of suicide attempts, while other findings suggested higher rates of suicidal behaviour and deaths among immigrants as compared to the native population. Also, a positive correlation was found between suicidal behaviour and specific countries of origin. Non-European immigrant women were at the highest risk for suicide attempts, a group which included young women of South Asian and black African origin. Risk factors among migrants and ethnic minorities were found to be: language barriers, worrying about family back home, and separation from family. The lack of information on health care system, loss of status, loss of social network, and acculturation were identified as possible triggers for suicidal behaviour. Overall, results suggest that specific migrant populations and ethnic minorities present a higher risk of suicidal behaviour than native populations, as well as a higher risk of death by suicide.

1 February 2014 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LSLivia Sanna
Livia Sanna
ASAmanda L. Stuart
Amanda L. Stuart
JPJulie Pasco
Julie Pasco
FJFelice N. Jacka
Felice N. Jacka
MBMichael Berk
Michael Berk
LWLana J. Williams
Lana J. Williams

Verified
Journal Article
Open access
PDF file
Maurizio PompiliMaurizio Pompili
Maurizio Pompili
RBRoss Baldessarini
Ross Baldessarini
AFAlberto Forte
Alberto Forte
DEDenise Erbuto
Denise Erbuto
Gianluca SerafiniGianluca Serafini
Gianluca Serafini
Paolo GirardiPaolo Girardi
Paolo Girardi
Modern antipsychotic drugs are employed increasingly in the treatment of mood disorders as well as psychoses, stimulating interest in their possible contributions to altering suicidal risk. Clozapine remains the only treatment with an FDA-recognized indication for reducing suicidal risk (in schizophrenia). We carried out a systematic, computerized search for reports of studies involving antipsychotic drug treatment and suicidal behaviors. A total of 19 reports provide data with preliminary support for potential suicide risk-reducing effects of olanzapine, quetiapine, ziprasidone, aripiprazole, and asenapine in addition to clozapine, and provide some support for antipsychotic drug treatment in general. These preliminary findings encourage further testing of antipsychotics for effects on suicidal behavior, making use of explicit, pre-planned assessments of suicidal behavior.

14 October 2014 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JLJuliana F. Lindau
Juliana F. Lindau
SMSimona Mastroeni
Simona Mastroeni
AGAndrea Gaddini
Andrea Gaddini
DLDomenico Di Lallo
Domenico Di Lallo
PNPaolo Fiori Nastro
Paolo Fiori Nastro
CFCristina Fortes
Cristina Fortes